Insta
‘Won’t Give Pain To Any Third Country On Bilateral Issues’: PM Modi Says On Kashmir Issue During Meeting With Trump
Swarajya Staff
Aug 26, 2019, 05:00 PM | Updated 05:00 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Prime Minister Narendra Modi and United States President Donald Trump met on the sidelines of the G7 Summit in Biarritz, France on Monday (26 August).
During their meet, both the leaders discussed wide range of matters, including the Kashmir issue.
“I had a talk with PM Modi on Kashmir, things are under control and I am hopeful India and Pakistan will be able to do something good very soon,” said Trump, as reported by Hindustan Times.
Trump said that he was hopeful that India and Pakistan would sort out all their differences soon.
Prime Minister said that all issues between India and Pakistan are bilateral and no third country mediation is required on them.
“All issues between India-Pak bilateral; don’t want to give pain to any third country,” PM Modi said on the Kashmir issue.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.